Enlivex Therapeutics Ltd (NYSE: ENLV) — Healthcare · Share Price, Chart & Market Data
About: Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.89 (-2.01%)
ENLVEnlivex Therapeutics Ltd
Loading watchlist status…
Trade ENLV now
Enlivex Therapeutics Ltd share price
ENLV price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 12:38 pm GMT+0
ENLV price performance
1.138%
5D
-15.381%
1M
17.682%
YTD
-13.738%
1Y
ENLV price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 12:38 pm GMT+0
ENLV details
ENLV Market Signals